Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
Chilblain lupus erythematosus can present with atypical features, such as nasal involvement, in addition to the more common acral lesions.
Dermatology July 31st 2024
Northwestern Medicine
Researchers have identified insufficient activation of the aryl hydrocarbon receptor (AHR) pathway as a key driver in lupus pathogenesis, offering a new target for therapeutic intervention.
Allergy & Immunology July 17th 2024
Lupus News Today
Researchers discovered that inhibiting the activity of the fumarate hydratase enzyme in macrophages (a type of immune cell that plays a key role in inflammatory disorders) increased the cells’ production of interferon-beta. They also discovered that lupus patients’ macrophages have abnormally low levels of fumarate hydratase. These findings suggest that dysregulation of this enzyme may be a factor in the development of lupus, and that fumarate hydratase could be a potential therapeutic target.
Rheumatology March 23rd 2023
ACP Internist
On exam, this 19-year-old woman has malar rash characterized by pink-violet papules and plaques with no other physical finding. ANA is positive and urinalysis is remarkable for 3+ blood and protein. What test is the most appropriate next step?
Dermatology January 25th 2023
Annals of Internal Medicine
Among more than 3,000 patients taking hydroxychloroquine, overall cumulative incidence for developing retinopathy were 2.5% and 8.6% at 10 and 15 years respectively. Incidence was strongly dose-related and most cases were mild.
Family Medicine/General Practice January 24th 2023